MANAGEMENT
Dr. Bennett Weintraub, PhD
Director
Ben is the President of inThought Research, Inc, a provider of decision support for life sciences companies and investors. After completing his studies at MIT, Stanford, UCSD, and Australia National University, Dr. Weintraub was a sell side biotech analyst and independent research provider prior to forming inThought in 2009.
Dr. Weintraub has served as a director since October 2023. Dr. Weintraub currently serves as the President of inThought Research (“inThought”), a healthcare business intelligence consulting firm which he founded in 2009. inThought provides business development support, competitive intelligence monitoring, medical conference coverage, and other services both to professional investors and to pharma / biotech companies.
Dr. Weintraub has also served as the Chief Scientific Officer of inPhronesis since 2018. After completing his training in immunology and biochemistry, Dr. Weintraub co-founded Biotech Tracker, an online tool for investors, where he served as a financial analyst from 2000 to 2008. From 2006 to 2008, Dr. Weintraub served as an analyst at Reuters Insight, providing analysis of drug development and trends in medicine to professional investors. Dr. Weintraub served as a licensed security analyst with Variant Research from 2005 to 2006. From 1999 to 2000, Dr. Weintraub was senior scientific editor for the biology research journals Cell and Molecular Cell.
Dr. Weintraub performed biochemistry and immunology research at Stanford University and at the John Curtin School of Medical Research in Canberra, Australia. He earned his doctorate in Biology from the University of California, San Diego, and a Bachelor of Science in Life Science from the Massachusetts Institute of Technology. We believe Mr. Weintraub’s extensive science background qualifies him to serve on our board of directors.